EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From recognition to delivery: nucleic acid aptamers in miRNA-related diagnosis and therapy of hepatocellular carcinoma

Shihao Du, Shaokang Wu, Ruomiao Li, Jing Du, Huaqiang Liu

Frontiers in Pharmacology · 04.11.2026 · 17

DOI: 10.3389/fphar.2026.2001917 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 04.11.2026. Verfasst von Shihao Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Qingdao Public Health Clinical Center, Shandong, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC), the most common primary malignant liver tumour, remains a major clinical challenge because of its low early diagnosis rate and high post-treatment recurrence. MicroRNAs (miRNAs) play key regulatory roles in HCC development and progression and are potential liquid biopsy biomarkers and therapeutic targets. However, the low abundance and instability of miRNAs in body fluids, together with the limitations of conventional detection methods, have hindered their clinical translation. Nucleic acid aptamers, owing to their high affinity, specificity, and ease of chemical modification, are valuable in miRNA-related detection and targeted delivery. This narrative review summarises technical strategies for aptamer-based and aptamer-inspired detection of HCC-associated miRNAs, as well as aptamer-guided miRNA delivery systems in HCC therapy. Importantly, most aptamers used in HCC research do not directly bind miRNAs; instead, they target HCC cells, surface proteins, or exosomes, whereas miRNAs serve as detection analytes or therapeutic cargo. It analyses the design logic and potential integration pathways of “recognition-delivery” platforms, while distinguishing conceptual integration from experimentally validated single-platform systems. Challenges and future directions are also discussed.

Schlagwörter

Stichwörter der Autor:innen

hepatocellular carcinomamiRNAnarrative reviewnucleic acid aptamerstargeted deliverytheranostics

Autor:innen und Institutionen

  • Department of Pharmacy, Qingdao Public Health Clinical Center, Shandong, China.
  • Qingdao Hospital of University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.

Zitieren

APA

Du, S., Wu, S., Li, R., Du, J., & Liu, H. (2026). From recognition to delivery: nucleic acid aptamers in miRNA-related diagnosis and therapy of hepatocellular carcinoma. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.2001917

Vancouver

Du S, Wu S, Li R, Du J, Liu H. From recognition to delivery: nucleic acid aptamers in miRNA-related diagnosis and therapy of hepatocellular carcinoma. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.2001917

BibTeX
@article{Du2026,
  author = {Du, Shihao and Wu, Shaokang and Li, Ruomiao and Du, Jing and Liu, Huaqiang},
  title = {From recognition to delivery: nucleic acid aptamers in miRNA-related diagnosis and therapy of hepatocellular carcinoma},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.2001917}
}
Kostenlos starten →